Patent · US Active

Treatment of hidradenitis suppurativa using JAK inhibitors

US11304949B2 · kind B2 · utility

6Cited by
122References
17Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMar 29, 2019
Grant dateApr 19, 2022
Priority date—
Expiry dateJun 20, 2039

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P17/10
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present application provides methods of treating hidradenitis suppurativa in a patient in need thereof, comprising administering to the patient a therapeutically effective amount of a compound which inhibits JAK1 and/or JAK2, or a pharmaceutically acceptable salt thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.